Southpoint Capital Advisors’s Elevance Health ELV Stock Holding History

Southpoint Capital Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-500,000	Closed	-$179M	–	57
2021 Q1	$179M	Sell	500,000 -100,000	-17%	-$32.2M	2.88%	11
2020 Q4	$193M	Hold	600,000	–	–	3.36%	9
2020 Q3	$161M	Sell	600,000 -115,000	-16%	-$30.9M	3.67%	8
2020 Q2	$188M	Sell	715,000 -35,000	-5%	-$9.34M	4.58%	5
2020 Q1	$170M	Buy	+750,000	New	+$204M	4.98%	5
2017 Q4	–	Sell	-250,000	Closed	-$47.5M	–	32
2017 Q3	$47.5M	Sell	250,000 -350,000	-58%	-$66.6M	1.95%	18
2017 Q2	$113M	Sell	600,000 -100,000	-14%	-$18M	4.46%	8
2017 Q1	$116M	Buy	+700,000	New	+$111M	4.91%	8

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Southpoint Capital Advisors's ELV Position: Q2 2021 in Review

Southpoint Capital Advisors sold out of Elevance Health (ELV) in Q2 2021, closing a stake of 500,000 shares — an estimated $179M sold.

Southpoint Capital Advisors first reported a position in ELV in Q1 2017 and held it in 8 quarters. The position peaked at $193M in Q4 2020. 1,234 funds tracked by Wall St. Rank hold ELV as of Q2 2021.

Southpoint Capital Advisors reported no remaining Elevance Health position as of Q2 2021 after selling out during the quarter.
Southpoint Capital Advisors sold 500,000 Elevance Health shares in Q2 2021, an estimated $179M.
Southpoint Capital Advisors first reported a position in Elevance Health in Q1 2017 and held it in 8 quarters.
Southpoint Capital Advisors's Elevance Health position peaked at $193M in Q4 2020.
1,234 funds tracked by Wall St. Rank held Elevance Health as of Q2 2021.

Based on Southpoint Capital Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.